(E)-guggulsterone, (Z)-guggulsterone, guggulsterone, pregna-4,17-diene-3,16-dione, pregna-4,17-diene-3,16-dione, (17E)-isomer, pregna-4,17-diene-3,16-dione, (17Z)-isomer
Name | Guggulsterone | ||
PubChem CID | 6450278 | ||
Molecular Weight | 312.4g/mol | ||
Synonyms |
(E)-guggulsterone, (Z)-guggulsterone, guggulsterone, pregna-4,17-diene-3,16-dione, pregna-4,17-diene-3,16-dione, (17E)-isomer, pregna-4,17-diene-3,16-dione, (17Z)-isomer |
||
Formula | C₂₁H₂₈O₂ | ||
SMILES | CC=C1C(=O)CC2C1(CCC3C2CCC4=CC(=O)CCC34C)C | ||
InChI | 1S/C21H28O2/c1-4-16-19(23)12-18-15-6-5-13-11-14(22)7-9-20(13,2)17(15)8-10-21(16,18)3/h4,11,15,17-18H,5-10,12H2,1-3H3/b16-4+/t15-,17+,18+,20+,21-/m1/s1 | ||
InChIKey | WDXRGPWQVHZTQJ-OSJVMJFVSA-N | ||
CAS Number | 39025-23-5 | ||
ChEMBL ID | CHEMBL410683 | ||
ChEBI ID | CHEBI:135338 | ||
Herb ID | HBIN028535 | ||
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | MoYao | ||
Use Part | Balsam | ||
Flavor | Pungent, Bitter | ||
Meridian Tropism | Heart, Liver, Spleen | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Sapindales
-->Family: Burseraceae
-->Genus: Commiphora
-->Species: Commiphora myrrha
|
Chineses Pinyin | MuKuErMoYao | ||
Use Part | Oil gum resin exuding from the stem bark | ||
Flavor | Pungent | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Dicotyledoneae
-->Order: Sapindales
-->Family: Burseraceae
-->Genus: Commiphora
-->Species: Commiphora mukul
|
Pair Name | Guggulsterone, Gemcitabine | |||
Partner Name | Gemcitabine | |||
Disease Info | [ICD-11: 2C10.0] | Pancreatic ductal adenocarcinoma | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Expression | BAX | hsa581 | |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Phosphorylation | MAPK8 | hsa5599 | |
Down-regulation | Activity | NFKB1 | hsa4790 | |
In Vitro Model | MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 | |
In Vivo Model | To ceate the subcutaneous xenograft model, mice were subcutaneously inoculated with MiaPaCa-2 cells (1×10⁶cells/mouse) in 1 mL of Matrigel. | |||
Result | The combination of guggulsterone to gemcitabine enhanced antitumor efficacy through apoptosis induction by suppressing Akt and nuclear factor KappaB activity and by modulating apoptosis-related protein expression in pancreatic cancer |
Pair Name | Guggulsterone, Doxorubicin | |||
Partner Name | Doxorubicin | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | ABCB1 | hsa5243 |
Down-regulation | Expression | BCL2 | hsa596 | |
In Vitro Model | MCF-7(DOX/R) | Invasive breast carcinoma | Homo sapiens (Human) | CVCL_C4M9 |
MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 | |
In Vivo Model | Transplantable cells (1×10⁷) were collected and subcutaneously injected in the right flanks of mice. | |||
Result | Further studies demonstrated the inhibitory effects of guggulsterone on Bcl-2 and P-glycoprotein expression were the possible reason to increase chemosensitivity of MCF-7/DOX cells to doxorubicin in vivo. Examining body weight, hematological parameters, hepatic, cardiac and gastrointestinal tracts histopathology revealed that no significant signs of toxicity were related to guggulsterone. Guggulsterone might reverse doxorubicin resistance in vivo, with no severe side effects. |
No. | Title | Href |
---|---|---|
1 | Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer. Pancreas. 2012 Oct;41(7):1048-57. doi: 10.1097/MPA.0b013e318249d62e. | Click |
2 | Reversal of doxorubicin resistance by guggulsterone of Commiphora mukul in vivo. Phytomedicine. 2014 Sep 25;21(11):1221-9. doi: 10.1016/j.phymed.2014.06.003. | Click |